BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Hemophilia Alliance - ECPv6.3.7//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Hemophilia Alliance
X-ORIGINAL-URL:https://hemoalliance.org
X-WR-CALDESC:Events for Hemophilia Alliance
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20260308T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20261101T060000
END:STANDARD
TZID:America/Phoenix
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0700
TZNAME:MST
DTSTART:20270101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20260923T130000
DTEND;TZID=America/New_York:20260923T140000
DTSTAMP:20260831T144343
CREATED:20260828T162902Z
LAST-MODIFIED:20260831T120027Z
UID:73534-1790168400-1790172000@hemoalliance.org
SUMMARY:🟥 Member Webinar : Hemophilia Alliance Hosts - A Webinar From Novo Nordisk - Preapproval Information Exchange: Denecimig for the treatment of hemophilia A
DESCRIPTION:Date: Wednesday\, September 23rd\, 2026\nTime: 1:00pm – 2:00pm ET \n \n \nWEBINAR TOPIC:\nPreapproval Information Exchange: Denecimig for the treatment of hemophilia A \nOBJECTIVES:\nDenecimig is a novel FVIIIa mimetic agent currently under investigation for the treatment of hemophilia A (congenital FVIII deficiency) with or without FVIII inhibitors. Denecimig has not been approved for any indication by any regulatory authority. This webinar will offer healthcare decision-makers an overview of the burden of disease in patients with hemophilia A\, a detailed introduction to denecimig\, its delivery (dosing and administration)\, and a summary of its clinical trial program. Denecimig is an investigational agent\, and its efficacy and safety have not been established. \n\nAUDIENCE:\nAll HTC Staff \nSPEAKER:\nCraig Schmidt\, PharmD\nMedical Accounts Associate Director\nNovo Nordisk Medical Affairs \nBefore joining Novo Nordisk in 2019\, Craig had been in the Community Pharmacy and Managed Care settings for 13 years and held various roles and leadership positions. Of note\, Craig was the Pharmacy Director of a Regional Health Plan that served over a million Medicaid\, Medicare\, and Commercially insured patients within the New York Metro area. \nCraig currently serves as a Medical Accounts Director for Novo Nordisk\, a global healthcare company with over 100 years of innovation and leadership in diabetes\, obesity\, and rare disease care. Craig is responsible for providing scientific support to payers\, specialty pharmacies\, and other stakeholders that advance the care for patients living with rare diseases. \nCraig earned his Doctor of Pharmacy from St. John’s University\, and is currently based out of Queens\, NY.
URL:https://hemoalliance.org/alliance-events/a-webinar-from-novo-nordisk-preapproval-information-exchange-denecimig-for-the-treatment-of-hemophilia-a/
CATEGORIES:Members Only
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20260927T183000
DTEND;TZID=America/New_York:20260929T173000
DTSTAMP:20260831T144343
CREATED:20250604T143303Z
LAST-MODIFIED:20260611T204255Z
UID:70983-1790533800-1790703000@hemoalliance.org
SUMMARY:🟥 Member Event : 2026 Fall Members Meeting & Hill Day
DESCRIPTION:Date: September 27 – 29\, 2026\nLocation: Washington\, DC \nPlease note: this button will redirect you to Cvent\, the Alliance’s NEW management registration platform. \n \n  \n  \n  \nPlease contact Theresa Parker with any questions regarding this registration at theresa@hemoalliance.org or 727-688-2568.
URL:https://hemoalliance.org/alliance-events/member-event-2026-fall-members-meeting-hill-day/
CATEGORIES:Members Only
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Phoenix:20270124T183000
DTEND;TZID=America/Phoenix:20270126T140000
DTSTAMP:20260831T144343
CREATED:20260810T124715Z
LAST-MODIFIED:20260810T124749Z
UID:73430-1800815400-1800972000@hemoalliance.org
SUMMARY:🟥 Member Event : 2027 MPBA Meeting
DESCRIPTION:Date: January 24 – 26\, 2027\nLocation: Salt Lake City\, UT \nPlease note: this button will redirect you to Cvent\, the Alliance’s NEW management registration platform. \n \n  \n  \nPlease contact Theresa Parker with any questions regarding this registration at theresa@hemoalliance.org or 727-688-2568.
URL:https://hemoalliance.org/alliance-events/member-event-2027-mpba-meeting/
CATEGORIES:Members Only
END:VEVENT
END:VCALENDAR